Analyze Diet
Equine veterinary journal2005; 37(1); 31-36; doi: 10.2746/0425164054406784

Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease.

Abstract: Cartilage oligomeric matrix protein (COMP) is abundant within cartilage; its turnover and/or degradation have been investigated in various equine joint diseases and it has been suggested that COMP fragmentation might be useful for monitoring such conditions. Objective: To determine whether COMP metabolism is compromised in equine osteoarthritis (OA) and whether COMP degradation is a useful joint marker representing cartilage destruction. Objective: A monoclonal antibody (mAb) with a higher affinity for degraded COMP allows discrimination of diseased joints by quantifying COMP levels and fragmentation. Methods: A mAb (clone14G4) was generated against equine cartilage COMP. The NH2-terminal sequence of enzyme-cut COMP fragments recognised by 14G4 was determined, as was the efficiency of binding to COMP (using a generated COMP peptide). COMP concentration and fragmentation were analysed in synovial fluid (SF) from normal horses and those with OA. Results: The mAb 14G4 had a higher affinity for the smaller fragments of equine COMP, compared with a mAb (clone 12C4) generated against human COMP. The 14G4 epitope was identified as between C134 and F147. The COMP values in OA (mean +/- s.d. 205.8 +/- 90.9 microg/ml) were significantly higher than in the normal (133.1 +/- 31.5 microg/ml) SF. On the immunoblots of OA sample, the proportions of intact COMP were significantly lower, while smaller fragments ranging from 75 to 290 kDa were higher compared with the normal SF. Conclusions: The mAb 14G4 reliably detects COMP degradation as well as synthesis, and fragmentation analysis combined with quantification in SF could be useful to study equine OA.
Publication Date: 2005-01-18 PubMed ID: 15651731DOI: 10.2746/0425164054406784Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on a molecule called cartilage oligomeric matrix protein (COMP) that exists abundantly in cartilage and how its change in turnover or degradation could be a useful indicator for monitoring equine joint diseases particularly osteoarthritis (OA). A monoclonal antibody was used to determine the fragmentation and levels of COMP, which ultimately showed that diseased joints had increased amounts of these fragments, indicating COMP degradation and suggesting their potential role as markers for disease progression.

Objective & Methods

  • The main objective of the research was to examine if COMP metabolism is affected in equine OA and if assessing COMP degradation can reliably represent cartilage destruction.
  • To explore this, a monoclonal antibody (clone14G4) was created against equine cartilage COMP. The team then evaluated the enzyme-cut COMP fragments recognized by clone14G4, as well as the efficiency of binding to COMP, using a generated COMP peptide.
  • The researchers then analyzed the COMP concentration and fragmentation in the synovial fluid – the lubricating fluid in joints – from normal horses and those suffering from OA.

Results

  • The monoclonal antibody clone 14G4 had a higher affinity for the smaller fragments of equine COMP, compared with another monoclonal antibody clone 12C4 that was generated against human COMP.
  • The sequence that clone 14G4 recognized on the COMP molecule was identified, located between two specific amino acids on the COMP molecule (C134 and F147).
  • COMP values in the synovial fluid of OA horses (average 205.8 micrograms/ml) were significantly higher than in the fluid of normal horses (average 133.1 micrograms/ml).
  • When analyzing OA samples, the proportions of intact COMP were significantly lower, indicating increased degradation, while smaller fragments of COMP were more abundant compared to the normal synovial fluid.

Conclusion

  • The monoclonal antibody 14G4 was able to detect COMP degradation as well as synthesis effectively, proving it could be a reliable tool in projecting the status of the COMP turnover in the system.
  • Through quantification and fragmentation analysis in synovial fluid, the study suggests that these methods could be valuable in studying equine OA, specifically in representing cartilage destruction.

Cite This Article

APA
Arai K, Misumi K, Carter SD, Shinbara S, Fujiki M, Sakamoto H. (2005). Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease. Equine Vet J, 37(1), 31-36. https://doi.org/10.2746/0425164054406784

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 37
Issue: 1
Pages: 31-36

Researcher Affiliations

Arai, K
  • Department of Veterinary Medicine, Kagoshima University, 21-24 Korimoto 1-chome, Kagoshima 890-0065, Japan.
Misumi, K
    Carter, S D
      Shinbara, S
        Fujiki, M
          Sakamoto, H

            MeSH Terms

            • Animals
            • Antibodies, Monoclonal
            • Biomarkers / metabolism
            • Cartilage Oligomeric Matrix Protein
            • Electrophoresis, Polyacrylamide Gel / veterinary
            • Enzyme-Linked Immunosorbent Assay / veterinary
            • Epitope Mapping / veterinary
            • Extracellular Matrix Proteins / metabolism
            • Female
            • Glycoproteins / metabolism
            • Horse Diseases / metabolism
            • Horses
            • Immunoblotting / veterinary
            • Joint Diseases / metabolism
            • Joint Diseases / veterinary
            • Joints / metabolism
            • Matrilin Proteins
            • Mice
            • Mice, Inbred BALB C
            • Osteoarthritis / metabolism
            • Osteoarthritis / veterinary
            • Peptide Fragments / chemistry
            • Synovial Fluid / chemistry

            Citations

            This article has been cited 8 times.
            1. Anderson JR, Phelan MM, Caamaño-Gutiérrez E, Clegg PD, Rubio-Martinez LM, Peffers MJ. Metabolomic and proteomic stratification of equine osteoarthritis. Equine Vet J 2025 Sep;57(5):1204-1218.
              doi: 10.1111/evj.14490pubmed: 39972657google scholar: lookup
            2. Lisee C, Obudzinski S, Pietrosimone BG, Alexander Creighton R, Kamath G, Longobardi L, Loeser R, Schwartz TA, Spang JT. Association of Serum Biochemical Biomarker Profiles of Joint Tissue Inflammation and Cartilage Metabolism With Posttraumatic Osteoarthritis-Related Symptoms at 12 Months After ACLR. Am J Sports Med 2024 Aug;52(10):2503-2511.
              doi: 10.1177/03635465241262797pubmed: 39129267google scholar: lookup
            3. Smith R, Önnerfjord P, Holmgren K, di Grado S, Dudhia J. Development of a Cartilage Oligomeric Matrix Protein Neo-Epitope Assay for the Detection of Intra-Thecal Tendon Disease. Int J Mol Sci 2020 Mar 20;21(6).
              doi: 10.3390/ijms21062155pubmed: 32245107google scholar: lookup
            4. Suyasa IK, Kawiyana IK, Bakta IM, Widiana IG. Interleukin-6 and ratio of plasma interleukin-6/interleukin-10 as risk factors of symptomatic lumbar osteoarthritis. World J Orthop 2017 Feb 18;8(2):149-155.
              doi: 10.5312/wjo.v8.i2.149pubmed: 28251065google scholar: lookup
            5. Clutterbuck AL, Smith JR, Allaway D, Harris P, Liddell S, Mobasheri A. High throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammation. J Proteomics 2011 May 1;74(5):704-15.
              doi: 10.1016/j.jprot.2011.02.017pubmed: 21354348google scholar: lookup
            6. Heinegård D, Saxne T. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 2011 Jan;7(1):50-6.
              doi: 10.1038/nrrheum.2010.198pubmed: 21119607google scholar: lookup
            7. Tseng S, Reddi AH, Di Cesare PE. Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis. Biomark Insights 2009 Feb 17;4:33-44.
              doi: 10.4137/bmi.s645pubmed: 19652761google scholar: lookup
            8. Lejeune JP, Serteyn D, Gangl M, Schneider N, Deby-Dupont G, Deberg M, Henrotin Y. Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing Ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Vet Res Commun 2007 Jul;31(5):591-601.
              doi: 10.1007/s11259-007-3518-2pubmed: 17252318google scholar: lookup